Abstract: An intubation device for placing a tracheal tube into a patient's trachea. The intubation device comprises a flexible light-wand having light emitting means placed in a distal end portion thereof. A distal portion of the flexible light-wand is adapted for placement inside the tracheal tube with the distal end portion thereof being in proximity to a distal end of the tracheal tube. The intubation device further comprises a coupling conduit. The coupling conduit has a tracheal tube port for being connected to the tracheal tube placed at a distal end thereof, a ventilating port for being connected to a ventilatory source, a monitoring port for being connected to a respiratory gas monitor, and a sealed aperture placed at a proximal end thereof. The sealed aperture accommodates the flexible light wand therethrough in a sealed fashion such that ventilating and monitoring of the patient is enabled while the flexible light wand is placed in the tracheal tube.

Abstract: An intubation device for placing a tracheal tube into a patient's trachea. The intubation device comprises a flexible light-wand having light emitting means placed in a distal end portion thereof. A distal portion of the flexible light-wand is adapted for placement inside the tracheal tube with the distal end portion thereof being in proximity to a distal end of the tracheal tube. The intubation device further comprises a coupling conduit. The coupling conduit has a tracheal tube port for being connected to the tracheal tube placed at a distal end thereof, a ventilating port for being connected to a ventilatory source, a monitoring port for being connected to a respiratory gas monitor, and a sealed aperture placed at a proximal end thereof. The sealed aperture accommodates the flexible light wand therethrough in a sealed fashion such that ventilating and monitoring of the patient is enabled while the flexible light wand is placed in the tracheal tube.

Abstract: An opioid formulation for pulmonary administration in the treatment or management of pain, a pulmonary drug delivery device containing, method of administering, kit containing, and uses of same. The formulation contains at least one rapid-onset opioid and preferably also contains a sustained-effect opioid to reduce the frequency of administration. The invention employs the side effects of the opioid formulation to permit patients to self-limit drug intake, thereby avoiding toxicity while achieving analgesia. A pharmacokinetic and pharmacodynamic model is employed to determine optimum drug formulations and optimum parameters for administration.

Abstract: An opioid formulation for pulmonary administration in the treatment or management of pain, a pulmonary drug delivery device containing, method of administering, kit containing, and uses of same. The formulation contains at least one rapid-onset opioid and preferably also contains a sustained-effect opioid to reduce the frequency of administration. The invention employs the side effects of the opioid formulation to permit patients to self-limit drug intake, thereby avoiding toxicity while achieving analgesia. A pharmacokinetic and pharmacodynamic model is employed to determine optimum drug formulations and optimum parameters for administration.

Abstract: An opioid formulation for pulmonary administration in the treatment or management of pain, a pulmonary drug delivery device containing, method of administering, kit containing, and uses of same. The formulation contains at least one rapid-onset opioid and preferably also contains a sustained-effect opioid to reduce the frequency of administration. The invention employs the side effects of the opioid formulation to permit patients to self-limit drug intake, thereby avoiding toxicity while achieving analgesia. A pharmacokinetic and pharmacodynamic model is employed to determine optimum drug formulations and optimum parameters for administration.

Abstract: An opioid formulation for pulmonary administration in the treatment or management of pain, a pulmonary drug delivery device containing method of administering, kit containing, and uses of same, The formulation contains at least one rapid-onset opioid and preferably also contains a sustained-effect opioid to reduce the frequency of administration. The invention employs the side effects of the opioid formulation to permit patients to self-limit drug intake, thereby avoiding toxicity while achieving analgesia. A pharmacokinetic and pharmacodynamic model is employed to determine optimum drug formulations and optimum parameters for administration.